Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2018MedChemCommOpen Access

Discovery of novel picolinamide-based derivatives as novel VEGFR-2 kinase inhibitors: synthesis, in vitro biological evaluation and molecular docking

View Full Paper
Ask AI
Bookmark
Share

Authors

WSWuji SunNorth China University of Science and TechnologySFShubiao FangHYHong YanBeijing University of Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sun et al. (2018) studied this question.

synapsesocial.com/papers/6aacd8f189fae1c2eb4775b7https://doi.org/10.1039/c8md00057c
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Discovery and development of sorafenib: a multikinase inhibitor for treating cancer2006 · 1,847 citations
  2. 2Clinical Implications of Circulating Angiogenic Factors in Cancer Patients2001 · 593 citations
  3. 3Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study2012 · 254 citations
  4. 4Assessment of the In vivo Antitumor Effects of ENMD-2076, a Novel Multitargeted Kinase Inhibitor, against Primary and Cell Line–Derived Human Colorectal Cancer Xenograft Models2010 · 42 citations
  5. 5Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 32008 · 638 citations